The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

21 articles for G Tóth


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
The effect of Pro(2) modifications on the structural and pharmacological properties of endomorphin-2.EBI
Biological Research Center of The Hungarian Academy of Sciences
Improving the permeability of the hydroxyethylamine BACE-1 inhibitors: structure-activity relationship of P2' substituents.EBI
Elan Pharmaceuticals
Endomorphin-2 with a beta-turn backbone constraint retains the potent micro-opioid receptor agonist properties.EBI
Biological Research Center of The Hungarian Academy of Sciences
Side chain methyl substitution in the delta-opioid receptor antagonist TIPP has an important effect on the activity profile.EBI
Vrije Universiteit Brussel
Synthesis, biological evaluation, and automated docking of constrained analogues of the opioid peptide H-Dmt-D-Ala-Phe-Gly-NH2 using the 4- or 5-methyl substituted 4-amino-1,2,4,5-tetrahydro-2-benzazepin-3-one scaffold.EBI
Vrije Universiteit Brussel
Design and synthesis of brain penetrant selective JNK inhibitors with improved pharmacokinetic properties for the prevention of neurodegeneration.EBI
Elan Pharmaceuticals
Design, synthesis, pharmacological evaluation, and structure-activity study of novel endomorphin analogues with multiple structural modifications.EBI
Hungarian Academy of Sciences
Design and synthesis of a novel, orally active, brain penetrant, tri-substituted thiophene based JNK inhibitor.EBI
Elan Pharmaceuticals
Highly selective c-Jun N-terminal kinase (JNK) 2 and 3 inhibitors with in vitro CNS-like pharmacokinetic properties prevent neurodegeneration.EBI
Elan Pharmaceuticals
Design and synthesis of disubstituted thiophene and thiazole based inhibitors of JNK.EBI
Elan Pharmaceuticals
Design of an orally efficacious hydroxyethylamine (HEA) BACE-1 inhibitor in a preclinical animal model.EBI
Elan Pharmaceuticals
Synthesis and opioid activity of novel 6-substituted-6-demethoxy-ethenomorphinans.EBI
University of Debrecen
New endomorphin analogues containing alicyclic beta-amino acids: influence on bioactive conformation and pharmacological profile.EBI
Hungarian Academy of Sciences
Beta-methyl substitution of cyclohexylalanine in Dmt-Tic-Cha-Phe peptides results in highly potent delta opioid antagonists.EBI
Hungarian Academy of Sciences
Ligand-based prediction of active conformation by 3D-QSAR flexibility descriptors and their application in 3+3D-QSAR models.EBI
University of Szeged
Structure-activity study on the Phe side chain arrangement of endomorphins using conformationally constrained analogues.EBI
Biological Research Center of The Hungarian Academy of Sciences
Deltorphin II analogues with 6-hydroxy-2-aminotetralin-2-carboxylic acid in position 1.EBI
Hungarian Academy of Sciences
Conformationally constrained deltorphin analogs with 2-aminotetralin-2-carboxylic acid in position 3.EBI
Hungarian Academy of Sciences
Indole derivatives and their use in neurodegenerative diseasesBDB
Merck Patent
Transition state analogs of 5'-methylthioadenosine nucleosidase disrupt quorum sensing.BDB
Albert Einstein College of Medicine